Acetyl salicylic acid treatment in neonatal Bartter syndrome--a commentary letter
- PMID: 21626220
- PMCID: PMC3119806
- DOI: 10.1007/s00467-011-1922-x
Acetyl salicylic acid treatment in neonatal Bartter syndrome--a commentary letter
Comment on
-
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.Pediatr Nephrol. 2011 Oct;26(10):1789-802. doi: 10.1007/s00467-011-1871-4. Epub 2011 Apr 19. Pediatr Nephrol. 2011. PMID: 21503667 Free PMC article. Review.
References
-
- Haas NA, Nossal R, Schneider CH, Lewin MA, Ocker V, Holder M, Uhlemann F. Successful management of an extreme example of neonatal hyperprostaglandin-E syndrome (Bartter's syndrome) with the new cyclooxygenase-2 inhibitor rofecoxib. Pediatr Crit Care Med. 2003;4(2):249–251. doi: 10.1097/01.PCC.0000059422.26706.64. - DOI - PubMed
-
- Engelhardt G, Homma D, Schlegel K, Utzmann R, Schnitzler C. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance. Inflamm Res. 1995;44(10):423–433. doi: 10.1007/BF01757699. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
